在存在或不存在静电相互作用的情况下,通过扩散辅助加载制备的阴离子纳米载体的siRNA输送
Olivia L Lanier1,2, Abielle P D'Andrea3,2, Aaliyah Shodeinde3,2
1Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX, USA.
Journal of applied polymer science
|July 4, 2024
概括
这项研究表明,小干扰RNA (siRNA) 如何装入纳米载体会对其释放产生重大影响. 优化负载条件可以导致治疗释放时间延长,提高治疗效率.
科学领域:
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
- 药物运输 药物运输 药物运输
背景情况:
- 子纳米载体正在探索治疗性小干扰RNA (siRNA) 的细胞内传递.
- 以前的研究集中在低pH值下siRNA加载,对加载方法影响的理解有限.
研究的目的:
- 研究不同siRNA加载方法对纳米载体释放动力学的影响.
- 优化纳米载体配方,以控制细胞内核酸的输送.
主要方法:
- 改造的阴离子纳米载体的开发,可控制pKa,大小,膨胀性和细胞相容性.
- 基于扩散的siRNA加载的评估,有和没有静电相互作用.
- 从使用各种负载条件 (pH,时间) 制备的纳米载体中分析siRNA释放动力学.
主要成果:
- 负载条件,包括pH值和持续时间,显然会影响纳米载体的siRNA释放行为.
- 基于扩散和静电辅助的加载机制都被研究了它们对释放型号的影响.
- 两种特定的纳米载体配方被评估为siRNA传递效率.
结论:
- 优化siRNA加载条件对于控制离子纳米载体的释放动力学至关重要.
- 这种方法提供了长时间细胞内释放核酸的潜力,减少了剂量频率.
- 这些发现支持化纳米粒子用于RNA干扰 (RNAi) 疗法和其他应用的发展.
相关概念视频
01:24Modified-Release Drug Delivery Systems: Site-Targeted
113
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
113
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
117
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
117